YOLFTbeta
41

PharmaEngine

4162 · TWO · Healthcare / Biotechnology

54.50TWD+1.50 (+2.83%)

Price History

Full chart

Market Stats

Previous Close53.00
Open53.30
Day Range53.20 – 54.80
52-Week Range51.29 – 72.00
Volume221.63K
Market Cap7.96B
P/E (TTM)14.81
Forward P/E6.27
EPS3.74
Dividend Yield3.61%
Beta0.14
50-Day Avg58.87
200-Day Avg61.06

About

PharmaEngine, Inc., a biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan. It offers ONIVYDE, a cancer medicine that blocks an enzyme called topoisomerase I, which is involved in copying cell DNA needed to make new cells. The company is also developing PEP07, a CHK1 inhibitor, which is in Phase 1 clinical trial for the treatment of hematological tumors and solid tumors. PharmaEngine, Inc. was incorporated in 2002 and is headquartered in Taipei, Taiwan.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Hong-Ren Wang Ph.D.
  • Employees45
  • Headquarters10 Minsheng East Road, Taipei, Taiwan, 104, Taiwan
  • Websitehttps://www.pharmaengine.com

Leadership

  • Mr. Hong-Ren Wang Ph.D.President & CEO
  • Yu Gen CaoAccounting Supervisor
  • Melody LinDirector of Human Resources

Financials

Income Statement

Currency: TWD2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue--320.05M184.03M37.40M228.99M507.24M1.13B853.68M293.43M314.04M1.06B654.84M654.38M767.67M2.52B911.42M
Growth (%)----42.50%-79.68%+512.26%+121.52%+123.72%-24.77%-65.63%+7.02%+236.27%-37.99%-0.07%+17.31%+228.70%-63.88%
Cost of Revenue--8.32M12.33M20.22M7.00M6.84M2.00M2.83M12.88M31.80M37.23M37.07M49.70M48.70M47.74M51.85M
Gross Profit--311.73M171.70M17.18M221.98M500.41M1.13B850.84M280.55M282.24M1.02B617.76M604.68M718.97M2.48B859.56M
Gross Margin--97.40%93.30%45.93%96.94%98.65%99.82%99.67%95.61%89.87%96.47%94.34%92.41%93.66%98.11%94.31%
Operating Expense--69.41M122.07M156.66M151.43M173.08M324.66M237.87M238.11M232.46M265.86M72.37M212.13M441.79M422.40M434.08M
Operating Income-106.25M-91.96M242.32M49.63M-139.48M70.55M327.33M808.12M612.97M42.44M49.78M752.92M545.39M392.55M277.18M2.05B425.48M
Operating Margin--75.71%26.97%-372.95%30.81%64.53%71.21%71.80%14.46%15.85%71.30%83.29%59.99%36.11%81.37%46.68%
EBITDA-96.69M-46.53M262.61M50.16M-139.15M70.83M328.96M811.12M616.02M45.37M56.49M765.48M555.65M401.16M286.20M2.17B519.48M
EBITDA Margin--82.05%27.26%-372.05%30.93%64.85%71.48%72.16%15.46%17.99%72.49%84.85%61.30%37.28%86.10%57.00%
Net Income-98.70M-48.15M285.71M48.99M-117.85M123.59M394.02M689.63M387.06M129.36M42.55M604.28M426.03M318.78M274.65M1.75B387.64M
Net Income Margin--89.27%26.62%-315.10%53.97%77.68%60.77%45.34%44.09%13.55%57.22%65.06%48.72%35.78%69.39%42.53%
R&D86.72M74.18M30.13M75.42M93.92M114.90M114.74M194.76M121.90M124.87M130.79M95.73M136.89M181.88M310.28M267.02M299.72M
R&D as % of Total Revenue--9.42%40.98%251.13%50.18%22.62%17.16%14.28%42.56%41.65%9.07%20.90%27.79%40.42%10.58%32.88%
Interest Expense36.00K25.00K----0000112.00K443.00K212.00K77.00K310.00K181.00K139.00K
Interest Expense % of Total Revenue------0.00%0.00%0.00%0.00%0.04%0.04%0.03%0.01%0.04%0.01%0.02%

Balance Sheet

Currency: TWD2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets41.79M95.27M634.07M1.65B2.74B2.94B3.24B3.96B4.11B3.85B3.64B4.21B4.03B3.97B3.95B5.85B5.15B
Total Liabilities30.50M13.85M15.59M14.20M25.90M18.02M79.41M160.48M199.90M152.67M160.40M195.78M87.70M94.47M91.01M448.01M221.59M
Total Equity11.29M81.42M618.48M1.63B2.72B2.93B3.16B3.80B3.91B3.69B3.48B4.01B3.94B3.87B3.86B5.40B4.93B
Cash7.11M80.13M598.59M1.61B2.70B2.90B432.52M1.84B575.36M358.35M92.77M1.84B2.15B1.77B875.62M993.70M1.58B
Total Debt1.48M3.06M1.66M1.54M2.83M1.93M3.91M299.00K632.00K1.15M33.37M22.08M7.59M22.35M14.81M--
Net Debt-5.62M-77.07M-596.93M-1.61B-2.70B-2.90B-428.60M-1.84B-574.73M-357.20M-59.40M-1.81B-2.14B-1.75B-860.81M--

Cash Flow

Currency: TWD2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-90.54M-57.26M275.49M68.64M-47.37M131.09M447.99M870.38M-339.30M745.23M16.08M64.77M929.67M202.01M256.97M456.73M1.73B
Investing Cash Flow-------2.73B649.74M-634.27M-600.96M-18.50M1.76B-107.00M-188.12M---
Financing Cash Flow75.10M112.33M239.04M941.80M1.14B70.74M-181.24M-111.28M-292.31M-361.25M-262.98M-87.50M-507.00M-395.71M-294.73M--
Capital Expenditure216.00K312.00K806.00K83.00K095.00K11.80M1.15M489.00K510.00K208.00K608.00K229.00K3.94M958.00K1.42M280.00K
Free Cash Flow-90.76M-57.57M274.68M68.56M-47.37M130.99M436.19M869.24M-339.79M744.72M15.87M64.16M929.44M198.07M256.01M455.32M1.73B
Dividends Paid------101.94M101.56M245.17M294.31M145.67M72.83M363.99M387.71M287.19M215.44M861.92M
FCF to OCF100.24%100.54%99.71%99.88%100.00%99.93%97.37%99.87%100.14%99.93%98.71%99.06%99.98%98.05%99.63%99.69%99.98%
Dividend Paid to FCF------23.37%11.68%-72.15%39.52%917.88%113.52%39.16%195.75%112.18%47.32%49.92%

Earnings

Report DateMay 15, 2013Aug 14, 2013Nov 13, 2013May 14, 2014Aug 13, 2014Nov 13, 2014Mar 31, 2015May 14, 2015Aug 14, 2015Nov 11, 2015Mar 30, 2016May 14, 2016Aug 10, 2016Nov 11, 2016Mar 14, 2017May 10, 2017Aug 8, 2017Nov 10, 2017Mar 28, 2018May 11, 2018Aug 13, 2018Nov 8, 2018Mar 30, 2019May 14, 2019Aug 11, 2019Nov 11, 2019Mar 23, 2020May 11, 2020Aug 5, 2020Nov 6, 2020Mar 21, 2021May 5, 2021Aug 11, 2021Nov 10, 2021Mar 8, 2022May 6, 2022Aug 3, 2022Nov 4, 2022Mar 2, 2023May 4, 2023Aug 4, 2023Nov 6, 2023Feb 28, 2024Apr 25, 2024Aug 5, 2024Nov 7, 2024Feb 27, 2025Apr 23, 2025Aug 11, 2025Nov 11, 2025Mar 11, 2026
EPS Estimate-0.20-0.15-0.59-0.14-0.151.26-0.31-0.133.05-0.230.80-0.291.83-0.454.370.33-0.30-0.244.170.060.190.41-0.020.140.180.140.160.110.02-0.010.25-1.130.420.610.640.560.130.150.430.410.560.460.490.820.654.170.540.690.940.79
EPS Actual-0.08-0.13-0.52-0.03-0.120.82-0.27-0.222.850.24-0.21-0.291.69-0.634.16-0.85-0.24-0.023.74-0.330.480.500.230.190.200.16-0.250.340.100.133.580.521.140.510.770.680.560.610.370.570.520.560.260.571.110.649.860.710.120.950.91
Surprise60.00%13.33%11.86%78.57%20.00%-34.92%12.90%-69.23%-6.56%204.35%-126.25%0.00%-7.65%-40.00%-4.81%-357.58%20.00%91.67%-10.31%-650.00%152.63%21.95%1250.00%35.71%11.11%14.29%-256.25%209.09%400.00%1400.00%1332.00%-0.89%21.43%26.23%6.25%0.00%369.23%146.67%32.56%26.83%0.00%-43.48%16.33%35.37%-1.54%136.45%31.48%-82.61%1.06%15.19%
TimingPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hours-After-hoursPre-marketAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-market

Key Statistics & Ratios

Market Cap7.96B
Enterprise Value3.04B
Trailing P/E14.81
Forward P/E6.27
Price / Sales7.77
Price / Book1.64
EPS3.74
Book Value34.17
Revenue (TTM)1.03B
Gross Profit (TTM)962.23M
EBITDA486.81M
Profit Margin52.56%
Operating Margin45.13%
Return on Equity11.26%
Return on Assets5.44%
Shares Outstanding143.68M
Shares Float93.46M
Beta0.14
Dividend Yield3.61%
Dividend Rate2.00
Payout Ratio107.53%

Dividends

20261×
2.00Aug 17, 2026
20251×
6.00Aug 13, 2025
20241×
1.50Aug 12, 2024
20231×
2.00Aug 15, 2023
20221×
2.70Aug 15, 2022
20211×
2.53Sep 13, 2021
20201×
0.50Jul 28, 2020
20191×
1.00Aug 28, 2019
20181×
2.00Aug 27, 2018
20171×
1.67Jul 26, 2017
20161×
1.16Jul 25, 2016
20151×
0.69Jun 30, 2015

Stock Splits

  • Jul 26, 20171199.953:1000
  • Jul 25, 20161199.919:1000